Fujifilm Kyowa Kirin Biologics Co. Ltd. today announced the company will partner with Mylan N.V. NASDAQMYL to commercialize FKB327 a biosimilar to Humira adalimumab developed by Fujifilm Kyowa Kirin Biologics. It has entered into a...
↧
Fujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize Biosimilar to Humira adalimumab
↧